Breaking News Instant updates and real-time market news.

MYL

Mylan

$35.94

-0.9 (-2.44%)

14:21
10/10/16
10/10
14:21
10/10/16
14:21

Fitch says Mylan settlement 'moves major risk aside'

Fitch in a press release says that Mylan's $465M settlement of claims it had misclassified its EpiPen injector "allays the otherwise significant risk of rebate recoup payments to Medicaid agencies related to the recent EpiPen scrutiny." The company remains subject to other government-related investigations, however, the ratings agency points out. It added, "The announcement brings a greater degree of certainty, and more quickly, than Fitch expected. Mylan will have sufficient liquidity to make the settlement payment without derailing expected de-leveraging subsequent to its mostly debt-funded acquisition of Meda. Still developing, however, is the impact of Mylan's pending launch of its own authorized generic version of EpiPen."

  • 09

    Nov

  • 28

    Mar

MYL Mylan
$35.94

-0.9 (-2.44%)

10/10/16
RAJA
10/10/16
UPGRADE
Target $57
RAJA
Strong Buy
Mylan upgraded to Strong Buy on EpiPen settlement at Raymond James
As previously reported, Raymond James upgraded Mylan two notches to Strong Buy from Market Perform and established a $57 price target. Analyst Elliot WIlbur said the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. With depressed absolute and relative valuation levels, Wilber sees favorable risk/reward scenarios even in a more tempered earnings growth environment.
10/10/16
JPMS
10/10/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan settlement, updated guidance a positive, says JPMorgan
JPMorgan analyst Chris Schott views Mylan's $465M settlement with the Department of Justice relating to the potential misclassification of Epipen in the Medicaid Drug Rebate Program as well as its updated 2016 guidance as a positive. The news "removes litigation overhang at a reasonable cost and highlights the diversification of the base business and inexpensive valuation," Schott tells investors in a research note. He keeps an Overweight rating on Mylan with a $52 price target.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Mylan settlement does not end EpiPen issue, says Wells Fargo
In a research note titled "Forget After Hrs. Quarterbacking - It is Not Back to Normal," Wells Fargo analyst David Maris says Mylan questions still remain after the company's lowered 2016 outlook and $465M Department of Justice settlement. One of Mylan's earnings levers, EpiPen pricing, is now off the table going forward, Maris tells investors in a research note. The analyst disagrees with investors that think the settlement puts the EpiPen pricing issue largely behind the company. The deal with the DOJ addresses only the Centers for Medicare and Medicaid Services portion of the issue, it does nothing to answer the original issue of EpiPen pricing and consumers, Maris contends. He points out that Mylan also disclosed in Friday's regulatory filing, but not in its press release, an SEC investigation by the Division of Enforcement. Maris says he's "not too excited" and doesn't gauge how good the news is by the after-hours share rally of 10%. He believes Mylan is "not back to normal" and keeps a Market Perform rating on the stock with a $43-$45 price target range. The shares are up 12% in pre-market trading to $40.35. Raymond James this morning upgraded Mylan to Strong Buy.
10/10/16
10/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mylan (MYL) upgraded to Strong Buy from Market Perform at Raymond James with Elliot WIlbur saying the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. 2. Under Armour (UA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Tom Nikic saying "noise" from the Sports Authority's bankruptcy is fading while distribution expansion could lead to sales re-acceleration over the next 12-18 months. 3. Deere (DE) and AGCO (AGCO) were upgraded to Outperform from Market Perform at Wells Fargo. 4. Dow Chemical (DOW) upgraded to Buy from Neutral at UBS with analyst John Roberts saying the merger with DuPont (DD) could gain regulatory approval and that the stock is "now too cheap to ignore." 5. Exelixis (EXEL) upgraded to Overweight from Neutral at Piper Jaffray with analyst Edward Tenthoff saying the data are "good enough" to file a supplemental new drug application and could drive off-label front-line RCC use. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NFX

Newfield Exploration

$28.45

0.89 (3.23%)

11:45
06/29/17
06/29
11:45
06/29/17
11:45
Options
Newfield Exploration call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

XLK

Technology Select Sector SPDR

$54.81

-0.96 (-1.72%)

, XLF

Financial Select Sector

$24.79

0.27 (1.10%)

11:38
06/29/17
06/29
11:38
06/29/17
11:38
Technical Analysis
Technical View: S&P 500 breaks 2420, bounces fractionally »

The S&P 500 (SPX)…

XLK

Technology Select Sector SPDR

$54.81

-0.96 (-1.72%)

XLF

Financial Select Sector

$24.79

0.27 (1.10%)

SPY

SPDR S&P 500 ETF Trust

$241.95

-1.54 (-0.63%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$91.56

1.7362 (1.93%)

11:30
06/29/17
06/29
11:30
06/29/17
11:30
Options
Bullish option play in JP Morgan as shares rally »

Bullish option play in JP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

11:25
06/29/17
06/29
11:25
06/29/17
11:25
General news
Treasury announced a $72 B 3- and 6-month bill auction for Monday »

Treasury announced a $72…

INFO

IHS Markit

$45.05

-0.32 (-0.71%)

11:25
06/29/17
06/29
11:25
06/29/17
11:25
Conference/Events
The National Economists Club to hold a luncheon meeting Symbol changed to INFO IHS Markit »

National Economists Club…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

QVCA

QVC Group

$24.61

0.1 (0.41%)

, QVCB

QVC Group

11:25
06/29/17
06/29
11:25
06/29/17
11:25
Conference/Events
FBN Securities media analyst to hold a luncheon meeting »

Media Analyst Routh…

QVCA

QVC Group

$24.61

0.1 (0.41%)

QVCB

QVC Group

LVNTA

Liberty Ventures

$52.69

1.21 (2.35%)

GNCMA

General Communications

$36.81

0.97 (2.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 10

    Jul

ALRN

Aileron Therapeutics

11:23
06/29/17
06/29
11:23
06/29/17
11:23
Syndicate
Breaking Syndicate news story on Aileron Therapeutics »

Aileron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

SHLD

Sears

$8.01

0.29 (3.76%)

11:22
06/29/17
06/29
11:22
06/29/17
11:22
Hot Stocks
Breaking Hot Stocks news story on Sears »

Returning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$8.01

0.29 (3.76%)

11:20
06/29/17
06/29
11:20
06/29/17
11:20
Hot Stocks
Breaking Hot Stocks news story on Sears »

Berkowitz says Fairholme…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$72.91

-0.01 (-0.01%)

11:20
06/29/17
06/29
11:20
06/29/17
11:20
Options
Abbvie attracts an opening call write »

Abbvie attracts an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$8.01

0.29 (3.76%)

11:17
06/29/17
06/29
11:17
06/29/17
11:17
Hot Stocks
Real estate value the 'margin of safety' in Sears investment, Berkowitz says »

Bruce Berkowitz,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
06/29/17
06/29
11:17
06/29/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$8.01

0.29 (3.76%)

11:16
06/29/17
06/29
11:16
06/29/17
11:16
Hot Stocks
Berkowitz sees Sears net asset value at $90 per share »

Bruce Berkowitz of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
06/29/17
06/29
11:16
06/29/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$961.01

12.92 (1.36%)

11:14
06/29/17
06/29
11:14
06/29/17
11:14
Technical Analysis
Technical View: Alphabet Class A has an active bearish pattern »

A bearish head and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$1.87

0.039 (2.13%)

11:13
06/29/17
06/29
11:13
06/29/17
11:13
Hot Stocks
Bombardier says Transportation restructuring costs included in previous guidance »

As part of the global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:11
06/29/17
06/29
11:11
06/29/17
11:11
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

11:11
06/29/17
06/29
11:11
06/29/17
11:11
General news
6-Month Bill Announcement Offering Amount data reported »

6-Month Bill Announcement…

11:11
06/29/17
06/29
11:11
06/29/17
11:11
General news
3-Month Bill Announcement Offering Amount data reported »

3-Month Bill Announcement…

DBD

Diebold

$27.88

0.425 (1.55%)

11:11
06/29/17
06/29
11:11
06/29/17
11:11
Hot Stocks
CMA says Diebold sale resolves concerns over cashpoint merger »

After the Competition and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHTR

Charter

$340.30

10.43 (3.16%)

11:10
06/29/17
06/29
11:10
06/29/17
11:10
Options
Renewed call buying in Charter »

Renewed call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

JCOM

j2 Global

$87.08

0.83 (0.96%)

, TWTR

Twitter

$17.74

-0.2132 (-1.19%)

11:06
06/29/17
06/29
11:06
06/29/17
11:06
Hot Stocks
IGN, Twitter partner for global live stream of San Diego Comic-Con »

J2 Global's (JCOM)…

JCOM

j2 Global

$87.08

0.83 (0.96%)

TWTR

Twitter

$17.74

-0.2132 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 28

    Sep

CY

Cypress Semiconductor

$14.35

1.15 (8.71%)

, ARW

Arrow Electronics

$79.00

-0.48 (-0.60%)

11:02
06/29/17
06/29
11:02
06/29/17
11:02
Hot Stocks
Cypress Semiconductor, Arrow Electronics announce IoT development platform »

Cypress Semiconductor…

CY

Cypress Semiconductor

$14.35

1.15 (8.71%)

ARW

Arrow Electronics

$79.00

-0.48 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 07

    Sep

PCYO

Pure Cycle

$7.50

-0.05 (-0.66%)

, KBH

KB Home

$23.57

-0.49 (-2.04%)

11:00
06/29/17
06/29
11:00
06/29/17
11:00
Hot Stocks
Pure Cycle to sell lots at Sky Ranch property to KB Home, Taylor Morrison »

Pure Cycle (PCYO)…

PCYO

Pure Cycle

$7.50

-0.05 (-0.66%)

KBH

KB Home

$23.57

-0.49 (-2.04%)

TMHC

Taylor Morrison

$23.91

-0.32 (-1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$34.08

-0.27 (-0.79%)

11:00
06/29/17
06/29
11:00
06/29/17
11:00
Options
AstraZeneca attracts a defensive option play »

AstraZeneca attracts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.